The high specificity and sensitivity cancer research, based on PCR and NGS methodologies, is highly dependent on the maintenance of sample integrity during and after collection.
Learn how to achieve optimal specimen stability by accessing the resources below at your own convenience!
Pre-analytical variable considerations in the development of robust cfDNA and RNA ddPCR assays. Dr. Carissa Moore, Streck and Dr. Hestia Mellert, Biodesix
Why and How of Blood Stabilization in cfDNA Analysis. Dr. Landon Olp and Justyna Tesmer, Streck
Pre-analytical Variables in Liquid Biopsy Assay Development; Dr. Carissa Moore, Streck and Ms. Inga Medina Diaz, Sysmex Inoastics
Frontline Genomics Editorial Roundtable
Pre-Clinical Research Aided by Customized Collection Capabilities
Evaluation of pre-analytical factors affecting plasma DNA analysis
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Cell-Free DNA BCT
Cell-Free DNA BCT Tech Note
Cell-Free DNA BCT® is Compatible with Bisulfite Conversion
Cell-Free DNA BCT® is for Research Use Only. Not for use in diagnostic procedures in the U.S.
A CE version of these tubes is also available.Cell-Free DNA BCT CE is for Export Only. Not for sale in the U.S. This is also licensed for sale in Canada.